No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: A positron emission tomography study

International Journal of Neuropsychopharmacology

Volumn 12, Issue 5, 2009, Pages 667-675

  Ito, Hiroshi ^a   Arakawa, Ryosuke ^a   Takahashi, Hidehiko ^a   Takano, Harumasa ^a   Okumura, Masaki ^a   Otsuka, Tatsui ^a   Ikoma, Yoko ^a   Shidahara, Miho ^a   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Antipsychotics; Dopamine D receptor; Occupancy; PET; Risperidone

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR; ISOREMOXIPRIDE; RACLOPRIDE C 11; RISPERIDONE; TRACER;

ADULT; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; HUMAN EXPERIMENT; LIMBIC CORTEX; MALE; MATHEMATICAL COMPUTING; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROVOCATION TEST; RECEPTOR BINDING; RECEPTOR OCCUPANCY; SIMULATION;

ADULT; BRAIN; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RECEPTORS, DOPAMINE D2; RISPERIDONE; YOUNG ADULT;

EID: 69749125065     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708009577     Document Type: Article

References (50)

1. 2 receptor occupancy in patients with schizophrenia. Psychopharmacology 197, 229-235.
2. Arnt J, Skarsfeldt T (1998). Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18, 63-101.
3. 11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region. Journal of Cerebral Blood Flow and Metabolism 27, 378-392.
4. Balsara JJ, Jadhav JH, Chandorkar AG (1979). Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology 62, 67-69.
5. Baron JC, Martinot JL, Cambon H, Boulenger JP, Poirier MF, Caillard V, Blin J, Huret JD, Loc'h C, Maziere B (1989). Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology 99, 463-472.
6. 123I]-epidepride SPET study. Journal of Clinical Psychopharmacology 23, 5-14.
7. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ (1997). Performance evaluation of a whole-body PET scanner using the NEMA protocol. Journal of Nuclear Medicine 38, 1614-1623.
8. Carlsson A, Lindqvist M (1963). Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacologica et Toxicologica 20, 140-144.
9. Creese I, Burt DR, Snyder SH (1976). Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481-483.
10. 123I]epidepride: resolving conflicting findings. NeuroImage 19, 1205-1214.
11. 11C]raclopride in man. Synapse 20, 200-208.
12. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Archives of General Psychiatry 49, 538-544.
13. 2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Archives of General Psychiatry 45, 71-76.
14. Fox PT, Mintun MA, Reiman EM, Raichle ME (1988). Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images. Journal of Cerebral Blood Flow and Metabolism 8, 642-653.
15. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS (1990). The relationship between global and local changes in PET scans. Journal of Cerebral Blood Flow and Metabolism 10, 458-466.
16. Gerlach J (1991). New antipsychotics: classification, efficacy, and adverse effects. Schizophrenia bulletin 17, 289-309.
17. 3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology 31, 1027-1035.
18. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997). Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage 6, 279-287.
19. 125I]epidepride. Synapse 23, 115-123.
20. 2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11, 245-256.
21. Hicks PB (1990). The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sciences 47, 1609-1615.
22. 11C]raclopride binding. Journal of Cerebral Blood Flow and Metabolism 18, 941-950.
23. 2 dopamine receptors in the human brain. NeuroImage 13, 531-539.
24. Ito H, Takahashi H, Arakawa R, Takano H, Suhara T (2008). Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography. NeuroImage 39, 555-565.
25. Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW (2006). Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Archives of General Psychiatry 63, 1079-1087.
26. 3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs. Pharmacology & Therapeutics 90, 231-259.
27. Kapur S, Remington G (1996). Serotonin-dopamine interaction and its relevance to schizophrenia. American Journal of Psychiatry 153, 466-476.
28. 2 receptor explain the action of atypical antipsychotics? A new hypothesis. American Journal of Psychiatry 158, 360-369.
29. 3 receptors by olanzapine and haloperidol. Neuropsychopharmacology 30, 2283-2289.
30. 2 receptors by clozapine and quetiapine. Neuropsychopharmacology 31, 1991-2001.
31. Kessler RM, Meltzer HY (2002). Regional selectivity in clozapine treatment? American Journal of Psychiatry 159, 1064-1065.
32. Korsgaard S, Gerlach J, Christensson E (1985). Behavioral aspects of serotonin-dopamine interaction in the monkey. European Journal of Pharmacology 118, 245-252.
33. 11C] raclopride studies. Journal of Cerebral Blood Flow and Metabolism 16, 42-52.
34. Lammertsma AA, Hume SP (1996). Simplified reference tissue model for PET receptor studies. NeuroImage 4, 153-158.
35. Leysen JE, Janssen PM, Megens AA, Schotte A (1994). Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. Journal of Clinical Psychiatry 55 (Suppl.), 5-12.
36. Meltzer HY, Matsubara S, Lee JC (1989). The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacology Bulletin 25, 390-392.
37. 18F-fallypride. Neuropsychopharmacology 25, 476-488.
38. 2A receptor occupancy in schizophrenic patients. American Journal of Psychiatry 156, 869-875.
39. 2 receptor occupancy-a simulation study based on experimental data. NeuroImage 14, 936-945.
40. 11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. Journal of Cerebral Blood Flow and Metabolism 19, 1164-1173.
41. Pilowsky LS, Mulligan RS, Acton PD, Ell PJ, Costa DC, Kerwin RW (1997). Limbic selectivity of clozapine. Lancet 350, 490-491.
42. Seeman P, Lee T, Chau-Wong M, Wong K (1976). Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261, 717-719.
43. 11C]FLB 457 binding in extrastriatal regions. Nuclear Medicine Communications 22, 1215-1221.
44. 2 receptor density and affinity in the human brain measured by 3D PET. International Journal of Neuropsychopharmacology 2, 73-82.
45. 2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics. International Journal of Neuro-psychopharmacology 7, 19-26.
46. Takano A, Suhara T, Yasuno F, Suzuki K, Takahashi H, Morimoto T, Lee YJ, Kusuhara H, Sugiyama Y, Okubo Y (2006). The antipsychotic sultopride is overdosed - a PET study of drug-induced receptor occupancy in comparison with sulpiride. International Journal of Neuropsychopharmacology 9, 539-545.
47. 11C]FLB 457. American Journal of Psychiatry 158, 926-930.
48. Watson CC, Newport D, Casey ME (1996). A single scatter simulation technique for scatter correction in 3D PET. In: Grangeat P, Amans JL (Eds), Three-dimensional Image Reconstruction in Radiology and Nuclear Medicine (pp. 255-268). Dordrecht, The Netherlands: Kluwer Academic Publishers.
49. 2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. British Journal of Psychiatry 179, 503-508.
50. 2 dopamine receptor occupancy with risperidone. Psychopharmacology 154, 112-114.